By Stephen G. Slade, MD
By STEVEN J. DELL, MD; MARK A. KONTOS, MD; COLMAN R. KRAFF, MD; LOUIS E. PROBST, MD; JOHN LEHR, OD; DAWN HOLSTED, OD; JO’EL STURM, OD; MITCHELL C. SHULTZ, MD; AND KARL G. STONECIPHER, MD
By WILLIAM B. TRATTLER, MD; ELENA ALBÉ, MD; AND RICHARD M. AWDEH, MD
By LOUIS D. “SKIP” NICHAMIN, MD; ROGER F. STEINERT, MD; ROBERT H. OSHER, MD; JAMES S. LEWIS, MD; CHARLES S. AHN, MD; AND ERIC D. DONNENFELD, MD
A surgeon reflects on what can be learned about an IOL simply by observing its light reflections. This article is the last in a three-part series.
By DANIEL H. CHANG, MD
By KEITH A.WALTER, MD & DAVID A. GOLDMAN, MD
By LAMA AL-ASWAD, MD; LAURA K. GREEN, MD; S. ANNA KAO, MD; NICK MAMALIS, MD; SUZANN PERSHING, MD; AND RICHARD TIPPERMAN, MD
Some say the conditions for medical innovation in this country have never been worse. What happened, and how do we fix it?
By JAMES J. INCOLLINGO, CORRESPONDING EDITOR
Founded to protect consumers from adulterated and misbranded food and drugs, the agency’s role is now supported by approximately 9,100 people.
By STEPHEN DAILY, NEWS EDITOR
By RHEA LLOYD, MD, SONAL WADHWA, MD MALVINA EYDELMAN, MD, AND ROBERT LEE KRAMM, MD
Although the Food and Drug Administration and the European Medicines Agency have similar evaluative processes, the final outcome of the benefit-risk assessment is not necessarily the same in all cases.
By JENNIFER KREATSOULAS, PHD, CONTRIBUTING EDITOR
Nonexpansile retinal gas can rapidly resolve corneal edema in patients with acute corneal hydrops.
By JOSEPH A. KHELL, MD; GABRIELA PEREZ; AND WILLIAM B. TRATTLER, MD
Jack T. Holladay,MD, discusses how he stays involved in ophthalmology after retirement and what inspired him to create the Brightness Acuity Test.
Avedro, Inc. (Waltham, MA), said that the FDA has granted an orphan drug designation for the company’s 0.1% riboflavin ophthalmic solution (VibeX) for use with its KXL System for corneal collagen cross-linking to treat kerato... more >
Bausch + Lomb (Rochester, NY) and Technolas Perfect Vision GmbH (Munich, Germany) introduced the Victus Femtosecond Laser Platform at the annual meeting of the European Society of Cataract and Refractive Surgeons in Vienna, Aus... more >
Despite an editor’s note addressing authorship at the start of the article, several readers have mistakenly thought that Section Editor David Chang, MD, wrote the article “Incorrect IOL Power” for the “Cataract Surgery ... more >
David J. Apple, MD, 69, a famed ophthalmologist and educator who worked tirelessly to legitimize and advance Sir Harold Ridley’s invention of the IOL, died August 18. During his career, which spanned more than 30 years, Dr. ... more >
Advertisement
It Is All About Building the Base
by ROCHELLE NATALONI, CONTRIBUTING EDITOR
A surgeon reflects on what can be learned about an IOL simply by observing its light reflections. This article is the last in a three-part series.
by DANIEL H. CHANG, MD
by LOUIS D. “SKIP” NICHAMIN, MD; ROGER F. STEINERT, MD; ROBERT H. OSHER, MD; JAMES S. LEWIS, MD; CHARLES S. AHN, MD; AND ERIC D. DONNENFELD, MD
by KEITH A.WALTER, MD & DAVID A. GOLDMAN, MD
Nonexpansile retinal gas can rapidly resolve corneal edema in patients with acute corneal hydrops.
by JOSEPH A. KHELL, MD; GABRIELA PEREZ; AND WILLIAM B. TRATTLER, MD